ArticleJournal of contemporary brachytherapy2026
The value of pre-brachytherapy MRI in aiding applicator selection for cervical cancer procedures.
Article in Journal of contemporary brachytherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Brachytherapy applicator selection in the treatment of cervical cancer often relies on intra-operative judgment. Pre-brachytherapy magnetic resonance imaging (pre-MRI) may provide earlier guidance for most appropriate applicator type and size across varying vaginal canal (VC) anatomies. This study investigated the relationship between pre-MRI VC volumes and applicator selection. Material and methods: One hundred and fourteen patients with cervical cancer treated with brachytherapy (2022-2024) were analyzed. Patient and treatment characteristics, including applicator type (tandem and ovoid [TO] vs. tandem and cylinder with needles [TC]), were collected. Pre-MRI with vaginal gel was used for optimal delineation of the upper 1 cm and 2 cm VC volumes, which were then analyzed in relation to applicator type and size selection. Results: Most patients had FIGO stage III-IV (75%) disease. The upper 2 cm VC volume was significantly associated with applicator selection across all fractions, with smaller volumes favoring TC applicators and larger volumes favoring TO applicators ( Conclusions: Pre-MRI VC volume measurements may aid in applicator selection; particularly upper 2 cm volumes < 4 cm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.